drugset / Trial / NCT07712575

A Study of V132 in Healthy Older Participants (V132-001)

NCT07712575

Phase 1 Not yet recruiting 280 enrolled Merck Sharp & Dohme LLC
RandomizedSequentialDouble-blindBasic science

Summary

The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.

Timeline

Start
2026-08-17
Primary completion
2028-06-21
Completion
2028-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject PCV20 Vaccine Intramuscular
Subject PCV21 Vaccine Intramuscular
Subject V132 Formulation 1 Vaccine Intramuscular
Subject V132 Formulation 2 Vaccine Intramuscular
Subject V132 Formulation 3 Vaccine Intramuscular

Indications

No indication recorded.